Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Diabetes prevention program outcome study

Next Previous
X
Search
Trial Profile

Diabetes prevention program outcome study

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Feb 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Metformin (Primary)
  • Indications Glucose intolerance; Hyperglycaemia; Metabolic syndrome; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms DPP; DPPOS

    • Most Recent Events

    • 24 Jan 2020 As per NCT00004992 the trial has been completed. Since the DPP trail is merged with DPPOS so the time period of the study has been increased. And the status is kept active, no longer recruiting as follow up study is ongoing as per results analysis have been followed for an average of 15 years since randomization.
    • 19 Jan 2020 Results (n=2776), assessing the risk of diabetes in women with risk of diabetes infertility and gravidity in diabetes prevention program outcome study (DPPOS) published in the Journal of Clinical Endocrinology and Metabolism
    • 19 Jul 2012 10 year follow-up (DPPOS year-5 ) Results published in the Diabetic Medicine.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top